Holen Sie sich die Stockscreener-App
11.42
0.71%
0.08
Handel nachbörslich:
11.26
-0.16
-1.40%
Finanzdaten der Intellia Therapeutics Inc-Aktie (NTLA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
49.10%
7.659
|
15.05 | 23.02 | 13.78 | 14.24 |
| Research and Development |
2.30%
82.59
|
80.74 | - | - | - |
| Costs And Expenses |
4.19%
120.42
|
115.58 | 121.73 | 125.26 | 124.24 |
| Operating Income/Loss |
12.16%
-112.76
|
-100.53 | -98.71 | -111.48 | -110.00 |
| Net Income/Loss |
10.81%
-106.63
|
-96.23 | -95.79 | -101.32 | -101.25 |
| Basic Average Shares |
12.65%
133.48
|
118.49 | 2.535 | 110.19 | 103.73 |
| Diluted Average Shares |
12.65%
133.48
|
118.49 | 2.535 | 110.19 | 103.73 |
| Basic Earnings Per Share |
1.23%
-0.80
|
-0.81 | -0.82 | -0.92 | -0.98 |
| Diluted Earnings Per Share |
1.23%
-0.80
|
-0.81 | -0.82 | -0.92 | -0.98 |
2.20%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):